6th Drug Discovery & Development Japan 2012

Drug Discovery & Development Japan is part of IBC’s longest running DDT brand and will continue to address the latest concerns of the Japanese as well as global pharmaceutical companies.
Japanese Pharma companies are increasingly open to partnerships to expand their exposure globally, signaling the best time for internationals to enter into the market. With a focus on partnerships, clinical trials and biologics R&D, Drug Discovery & Development Japan will provide the platform for networking as well as an insight into the Japanese markets for MNCs wanting to learn more.
+ show speakers and program
Dr Kentaro Yoshimatsu, Senior Scientific Advisor, Eisai

Norikazu Eiki, Chairman, Bayer Yakuhin


Dr Junichi Koga, Vice President Biopharmaceuticals, Daiichi-Sankyo

Motoya Kohtani, Senior Analyst, Nomura

Dinesh Dua, CEO, Nectar Lifesciences

KB Sankara Rao, Independent Consultant, Dr Reddy’s

Yariv Hefez, Head, Global Business Development & Alliance Management Biosimilars,
Merck Serono

Ralf Altmeyer, Director General, Institut Pasteur

Dr Binhui (Ben) Ni, Head of Scouting & Partnership, Sanofi-Aventis


Dr Nobuo Hanai, CEO, Kyowa Hakko Kirin

Dr Tadashi Matsumoto, President, ReqMed

Dr Se-Ho Kim, Research Director, Green Cross Corp

Tadashi Fujisawa, CEO, Mebiopharm Co Ltd

Ian Haydock, Asia Editor, SCRIP Intelligence

Dr Youling Wu, CEO, Zhejiang Teruisi

Dr Tsuneaki Sakata, Head, Innovation Design Office, Global Development, Shionogi & Co Ltd

Dr Rami Suzuki, Senior Director, Head of Business Development Department, Eisai


Dr Osamu Sato, Senior Director, R&D Planning Department, Daiichi Sankyo

Joshua Owide, Senior Analyst, PharmaVitae, Datamonitor

Eric Risser, Vice President, Business Development, MacroGenics

Pabel Delgado, Founder & Board Member, Asterism Healthcare Plus

Hideaki Nomura, Deputy Director, Strategic Product Planning Department & Biosimilar Project Leader, Kyowa Hakko Kirin

Hiroshi Sugii, Vice President, Clinical Development, Novo Nordisk

Shunsuke Izuka, Associate Manager, Clinical Development Group, Asia Development Department, Daiichi Sankyo

Dr Hisafumi Okabe, Vice President, General Manager, Research Division, Chugai Pharmaceutical

11 Jun - 14 Jun 2012
Tokyo
Japan
meeting website